MEDNAX (MD) Tops Q4 EPS by 2c, Revenues Beat; Offers 1Q EPS Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. SPY
10. FISV

Go back to MEDNAX (MD) Tops Q4 EPS by 2c, Revenues Beat; Offers 1Q EPS Guidance Below Consensus

MEDNAX Reports Fourth Quarter GAAP EPS of $0.68; Adjusted EPS of $0.92

February 7, 2019 6:00 AM EST

Provides Guidance for First Quarter and Full Year 2019

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.68 per diluted share for the three months ended December 31, 2018. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $0.92.

For the 2018 fourth quarter, MEDNAX reported the following results:

Net revenue of $933 million; Net income of $60 million; and... More